Sergio Lopresti

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

Camila Peña, Eloísa Riva, Natalia Schütz et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 28 citations · Full text

Medicine, Hematology, Oncology +14

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study

Eloísa Riva, Patricio Duarte, Bryan Valcárcel et al. · JCO Global Oncology · 2022 · 23 citations · Full text

Medicine, Internal Medicine, Oncology +12

Surveillance of growth-retarded fetuses with computerized fetal heart rate monitoring combined with Doppler velocimetry of the umbilical and uterine arteries.

Z. Weiner, George Farmakides, H Schulman et al. · PubMed · 1996 · 17 citations

Medicine, Obstetrics, Maternal-fetal Medicine +16

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Humberto Martínez‐Cordero, Camila Peña, Natalia Schütz et al. · JCO Global Oncology · 2023 · 11 citations · Full text

Medicine, Hematology, Internal Medicine +13

Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

Natalia Schütz, Paola Ochoa, Patricio Duarte et al. · Hematological Oncology · 2020 · 10 citations

Medicine, Hematology, Pharmacotherapy +17